BAXALTA VENTURES
Baxalta Ventures invests globally in healthcare companies developing novel products and therapies consistent with Baxalta’s commitment to strive for excellence on behalf of patients, caregivers and healthcare providers. The Baxalta Ventures team brings unique expertise in products and therapies across the pharmaceuticals, medical devices, and biotechnology sectors. As part of Baxalta, they have access to additional expertise in product research, development, manufacturing, and commercializa... tion to their work with entrepreneurs. Baxalta Ventures believe that establishing strong relationships with entrepreneurs, other venture capital investors, and industry experts is critical for the long-term success of their portfolio companies. They aim to accelerate and enhance commercialization activities in portfolio companies by creating strategic alliances with other venture capital funds and by leveraging Baxalta’s expertise in clinical development, production, and marketing of therapeutic solutions. Baxalta Ventures is managed by an experienced leadership team with extensive expertise in venture capital, scientific innovation, and operational leadership in the healthcare industry. Their initial investments are generally up to $5 million and may increase throughout the life of the company.
BAXALTA VENTURES
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
2015-01-01
Status:
Active
Contact:
44 (0) 20 3655 2400
Technology used in webpage:
SPF DMARC Pound Sterling Amazon Route 53 ATT
Similar Organizations
Asymmetric Capital Partners
Asymmetric Capital Partners is an venture capital firm focused on disruptive B2B technologies.
Basis Set Ventures
Basis Set Ventures is an early-stage investment firm focused on artificial intelligence and its practical application.
Cowboy Ventures
Cowboy Ventures is a generalist seed-stage fund focused fund investing in technology startups.
F-Prime Capital
F-Prime Capital is a venture capital firm investing in healthcare and technology.
FusionX Ventures
FusionX Ventures is an early-stage investment fund focused on helping companies build the next generation of cloud-enabled Smart Machines.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Smash Ventures
Smash Ventures is a later-stage investment firm focused on consumer internet and technology companies.
Tau Ventures
Tau Ventures is an investment fund that supports digital health, automation cars, drones, and robots enterprises.
Walkabout Ventures
Walkabout Ventures is an investment fund focused on venture funds investing in financial service startups.
ZMT Capital
ZMT Capital is a technology-driven investment firm focused on FinTech, mobile, hardware, AI, blockchain, and cryptocurrencies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-06-21 | Syntimmune | Baxalta Ventures investment in Series B - Syntimmune | 50 M USD |
| 2016-11-17 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 8 M USD |
| 2016-03-29 | Gadeta | Baxalta Ventures investment in Series A - Gadeta | 7 M EUR |
| 2016-03-22 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 10 M USD |
| 2015-12-03 | True North Therapeutics | Baxalta Ventures investment in Series C - True North Therapeutics | 40 M USD |
| 2014-10-24 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 8 M USD |
More informations about "Baxalta Ventures"
Baxalta Ventures | Investor profile | Foundersuite
Baxalta Ventures believe that establishing strong relationships with entrepreneurs, other venture capital investors, and industry experts is critical for the long-term success of their portfolio …See details»
Baxalta Ventures - Investments, Portfolio & Company Exits
Jun 21, 2017 Baxalta Ventures has invested in True North Therapeutics on Jun 21, 2017. This investment - Series C - True North Therapeutics - was valued at . obfuscated. obfuscated. …See details»
Baxalta - Crunchbase Company Profile & Funding
Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including …See details»
Baxalta Ventures investment portfolio | PitchBook
Baxalta Ventures's latest investment was on 23-Mar-2017 in OncoResponse, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how …See details»
Baxalta Company Profile 2024: Valuation, Investors, …
Baxalta Ventures: Corporate Venture Capital: Cambridge, MA: To view Baxalta’s complete subsidiaries history, request access » Baxalta Exits (4) Baxalta’s most recent exit was on 25-Feb-2016 from Precision BioSciences. The exit was …See details»
Baxter Ventures, Mayo Clinic and Velocity …
Jun 1, 2015 Following the spin-off of Baxter BioScience as Baxalta Incorporated, anticipated to take place by mid-2015, the Vitesse relationship will be managed by the planned venture arm, Baxalta Ventures, for the new company. Baxter …See details»
Baxalta: A Deep Valued Product Pipeline And Attractive …
Jan 21, 2016 Baxalta Ventures: This is the newly formed venture capital arm of Baxalta aimed at providing seed capital to promising healthcare firms. I expect significant promising investments in biotechnology ...See details»
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical …
Jun 1, 2015 Following the spin-off of Baxter BioScience as Baxalta Incorporated, anticipated to take place by mid-2015, the Vitesse relationship will be managed by the planned venture arm, …See details»
Shire, Baxalta Complete $32B Merger - genengnews.com
Jun 3, 2016 Baxalta shareholders will receive a combination of $18 in cash and 0.1482 Shire ADS's for each Baxalta share—or 0.4446 of a Shire ordinary share if the Baxalta shareholder …See details»
Baxalta Ventures - Contacts, Employees, Board Members
Baxalta Ventures has 2 current employee profiles, including Managing Partner, Baxalta Ventures Geeta Vemuri. Contacts. Edit Contacts Section. Job Department. Protected Content. Director …See details»
Baxalta - Wikipedia
Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound' [2]) is a biopharmaceutical company founded on 1 July 2015 after its parent …See details»
Shire completes combination with Baxalta creating the global
Forward-Looking Statements . Statements included herein that are not historical facts, including without limitation statements concerning the financial and strategic benefits of the combination …See details»
Baxalta: Examining the Product and Manufacturing Positions of …
Jul 8, 2015 Baxalta said it plans to launch 20 new products by 2020. Over the past two years, Baxalta has received seven new approvals and currently has four products under regulatory …See details»
Blake Randolph - Xeris Pharmaceuticals, Inc. | LinkedIn
Director, Finance at Xeris Pharmaceuticals, Inc. · Experience: Xeris Pharmaceuticals, Inc. · Education: University of Iowa · Location: Chicago · 500+ connections on LinkedIn. View Blake ...See details»
UPDATED: Baxalta signs off on a $1.6B checkpoint pipeline deal as …
Jan 4, 2016 Even as word of a looming Shire buyout continued to heat up over the weekend, Baxalta was readying an announcement that it has struck a deal with Copenhagen-based …See details»
Raphael Danon: Positions, Relations and Network - MarketScreener
Oct 30, 2024 Chief Executive Officer at Woodbridge Ventures II, Inc., Discover Raphael Danon's known position history, network and 99 relationships. ... (CPA) is a national accounting …See details»
Marta New - Principal @ Baxalta Ventures - Crunchbase
Senior associate at Baxter Ventures, where she was responsible for search, evaluation, and execution of strategic equity investments. Senior marketing manager at Baxter Healthcare, …See details»
Leading Global CDMO for Pharma & Biotech | Catalent
Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.See details»
Nearly 40,000 Northern Virginia businesses received PPP loans
Jul 10, 2020 Nearly 7,000 Northern Virginia companies and nonprofits have received Payroll Protection Plan loans of at least $150,000 apiece from the Small Business Administration, and …See details»